NeOnc adds First Abu Dhabi Bank executive Ali Alabedin to its board

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) announced on October 14, 2026 that it had appointed Ali Alabedin to its Board of Directors, effective October 9, 2026.¹ Per the company's 8-K filing, the Board appointed Ali Mohammad Ahmad Alabedin as a director on October 9, 2026, and he will serve as a Class I director with a term running until the 2029 annual meeting of stockholders.¹

Alabedin is Head of Islamic Banking Group at First Abu Dhabi Bank, which the company describes as the UAE's largest bank by total assets, reporting AED 1.41 trillion in total assets as of June 30, 2026.¹ According to the filing, he has held that role since August 2022, overseeing strategic direction, governance, financial performance, regulatory compliance and business growth for the bank's Islamic Banking franchise domestically and internationally.¹ Earlier in his career, he held senior roles at Standard Chartered Bank in the Middle East and South Asia, at ANZ Banking Group, and he founded Dubai Islamic Financial Services as CEO after being appointed by the chairman of Dubai Islamic Bank in January 2005.¹

The appointment comes as NeOnc reported regulatory progress for its brain cancer program. The Department of Health – Abu Dhabi authorized an Investigational New Drug application for NEO212, a step the company said supports plans for Phase 2 development in the UAE, pending required ethics approvals and other conditions before enrollment.¹ Separately, the filing notes NEO212 has completed Phase 1 dose escalation and is advancing toward Phase 2 development.¹

Alabedin succeeds Dr. Steven L. Giannotta, who notified the company of his resignation from the board effective October 9, 2026, a departure the filing states was not due to any disagreement with the company.¹ The filing also states there is no arrangement or understanding between Alabedin and any other person regarding his selection as director, and no family relationships with any director or officer.¹